by Investment in Japan
Private Equity in Japan
Cool Japan Fund is pleased to announce the investment of approximately 3 billion yen in Spiber Inc. (headquartered in Tsuruoka, Yamagata; hereafter “Spiber”), a biotech venture company launched out of the Keio University Institute for Advanced Biosciences in 2007. Spiber engages in the development and production of synthetic proteins based on engineered spider silk DNA. Funds raised from this round, in which the Cool Japan Fund was the lead investor, will be used to propel Spiber’s transition into the commercialization phase.
TOKIO MARINE CAPITAL CO., LTD. (“TMC”) announced that TMCAP2016 limited partnership, which is an investment fund managed by TMC, made an investment in Asahi House Industry Co., Ltd..